OLMA logo

Olema Pharmaceuticals (OLMA) Enterprise Value

Enterprise Value

$315.33 M
-$8.59 M-2.65%

2 min ago


Summary


Performance

OLMA Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherOLMAvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

OLMA Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-2.6%-2.4%-2.4%
1 m1 month+15.8%+14.0%+14.0%
3 m3 months--48.5%-48.5%
6 m6 months-54.5%-50.7%-50.7%
ytdytd+5.2%+4.6%+4.6%
1 y1 year-58.3%-57.5%-59.2%
5 y5 years---

OLMA Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-8.3%$259 M+21.7%
3 m3-month$567 M-44.4%$259 M+21.7%
6 m6-month$783 M-59.8%$259 M+21.7%
1 y1-year$910 M-65.4%$259 M+21.7%
3 y3-year$910 M-65.4%$61 M+417.1%
5 y5-year$2.06 B-84.7%$61 M+417.1%
alltimeall time$2.06 B-84.7%$61 M+417.1%

Olema Pharmaceuticals Enterprise Value History

DateValue
2025
$315.33 M(+5.2%)
2024
$299.86 M(-57.5%)
2023
$705.48 M(+786.5%)
DateValue
2022
$79.58 M(-78.0%)
2021
$361.98 M(-76.7%)
2020
$1.55 B

FAQ

  • What is Olema Pharmaceuticals enterprise value?
  • What is the all time high enterprise value for Olema Pharmaceuticals?
  • What is OLMA enterprise value year-to-date change?
  • What is Olema Pharmaceuticals enterprise value year-on-year change?

What is Olema Pharmaceuticals enterprise value?

The current enterprise value of OLMA is $315.33 M

What is the all time high enterprise value for Olema Pharmaceuticals?

Olema Pharmaceuticals all-time high enterprise value is $2.06 B

What is OLMA enterprise value year-to-date change?

Olema Pharmaceuticals enterprise value has changed by +$15.47 M (+5.16%) since the beginning of the year

What is Olema Pharmaceuticals enterprise value year-on-year change?

Over the past year, OLMA enterprise value has changed by -$440.14 M (-58.26%)